These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9365772)

  • 1. HIV-1 neurocognitive disorders and chemokine receptors.
    Barroga CF; Ellis R; Nelson J; Heaton RK; Atkinson JH; McCutchan JA; Grant I; Spector SA
    AIDS; 1997 Nov; 11(13):1651-2. PubMed ID: 9365772
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
    J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
    Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
    Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.
    Gonzalez S; Tirado G; Revuelta G; Yamamura Y; Lu Y; Nerurkar VR; Yanagihara R
    Bol Asoc Med P R; 1998; 90(1-3):12-5. PubMed ID: 9734151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the CCR5-delta 32 chemokine receptor gene mutation in the Lebanese population.
    Karam W; Jurjus R; Khoury N; Khansa H; Assad C; Zalloua P; Jurjus A
    East Mediterr Health J; 2004; 10(4-5):671-5. PubMed ID: 16335661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of CCR5 polymorphism in the development of AIDS dementia complex.
    Boven LA; van der Bruggen T; van Asbeck BS; Marx JJ; Nottet HS
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):243-7. PubMed ID: 10575135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of a CCR5 gene 32-bp deletion in an Israeli cohort of HIV-1-infected and uninfected hemophilia patients.
    Kantor R; Barzilai A; Varon D; Martinowitz U; Gershoni JM
    J Hum Virol; 1998; 1(4):299-301. PubMed ID: 10195255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production.
    Yang JY; Togni M; Widmer U
    Cytokine; 1999 Jan; 11(1):1-7. PubMed ID: 10080873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of co-receptor usage of HIV-1.
    Schuitemaker H; Kootstra NA
    Methods Mol Biol; 2005; 304():327-32. PubMed ID: 16061986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR-5 genotype and sexual transmission of HIV-1.
    O'Brien TR; Padian NS; Hodge T; Goedert JJ; O'Brien SJ; Carrington M
    AIDS; 1998 Mar; 12(4):444-5. PubMed ID: 9520179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals.
    Poljak M; Tomazic J; Seme K; Maticic M; Vidmar L
    Acta Virol; 1998 Feb; 42(1):23-6. PubMed ID: 9645239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.